INCY : Summary for Incyte Corporation - Yahoo Finance

U.S. Markets open in 1 hr 16 mins

Incyte Corporation (INCY)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
134.02+2.81 (+2.14%)
At close: 4:00PM EST
People also watch
VRTXBMRNALXNREGNMYGN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close131.21
Open131.88
Bid133.45 x 1000
Ask135.30 x 1000
Day's Range130.25 - 134.96
52 Week Range60.30 - 134.97
Volume8,345,985
Avg. Volume1,983,862
Market Cap25.38B
Beta1.67
PE Ratio (TTM)248.19
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Exelixis Rockets On Bristol, Roche I-O Ties Following Merck-Incyte Team
    Investor's Business Daily16 hours ago

    Exelixis Rockets On Bristol, Roche I-O Ties Following Merck-Incyte Team

    Exelixis is teaming up with Bristol-Myers Squibb and Roche to test its Cabometyx and their immuno-oncology drugs in liver and bladder cancer.

  • American City Business Journals23 hours ago

    Delaware biopharm company moves to S&P 500, inks alliance with Penn

    A Delaware-based biopharmaceutical company is headed to the S&P 500, a change that will become effective at the start of trading on Tuesday. Incyte (INCY) will replace Spectra Energy Corp. (SE) on the biotechnology sub-industry index . The announced shift came a day after the Wilmington biopharma firm and University of Pennsylvania announced a new research alliance that will focus on assessing new cancer treatments under development and advancing immunotherapy to fight cancer.

  • Zacksyesterday

    5 Toxic Stocks to Abandon or Play Short Right Now

    In general, toxic stocks are burdened with huge debt loads and vulnerable to external shocks.